Centrosome aberrations after nilotinib and imatinib treatment in vitro are associated with mitotic spindle defects

Alice Fabarius1, Michelle Giehl, Oliver Frank

  • 1III. Medizinische Universitätsklinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany. alice.fabarius@med3.ma.uni-heidelberg.de

Insights

The tyrosine kinase inhibitors imatinib and nilotinib cause centrosome and chromosome damage in human cells. These drugs disrupt mitotic spindle organization and genetic stability, highlighting the importance of targeted kinases in maintaining cell integrity.

Area of Science:

  • Cell Biology
  • Genetics
  • Pharmacology

Background:

  • Centrosomes are crucial for cell division, ensuring accurate chromosome segregation and genetic stability.
  • Previous research indicated that imatinib can induce centrosome and chromosome abnormalities in vitro.
  • Tyrosine kinases are key regulators of cellular processes, including those involving centrosomes.

Purpose of the Study:

  • To compare the effects of imatinib and nilotinib on centrosome, mitotic spindle, and karyotype status in human fibroblasts.
  • To investigate whether these drugs, targeting similar tyrosine kinases, impact genomic integrity.
  • To understand the role of targeted tyrosine kinases in maintaining centrosome and karyotype stability.

Main Methods:

  • Primary human fibroblasts were treated with therapeutic doses of imatinib and/or nilotinib.
  • Drugs were administered separately, consecutively, or in combination.
  • Centrosome, mitotic spindle, and karyotype status were analyzed to assess aberrations.

Main Results:

  • Both imatinib and nilotinib, individually or in combination, induced significant centrosome aberrations.
  • Mitotic spindle organization and karyotype status were similarly disrupted by the treatments.
  • The observed aberrations were consistent across different administration schedules.

Conclusions:

  • Distinct tyrosine kinases targeted by imatinib and nilotinib are essential for maintaining centrosome integrity.
  • Disruption of these kinases leads to mitotic spindle and karyotype abnormalities.
  • These findings underscore the critical role of specific tyrosine kinases in safeguarding genomic stability.

Related Concept Videos

Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Centrosome Duplication02:25

Centrosome Duplication

The primary microtubule organizing center (MTOC) in animal cells is the centrosome. A centrosome has two cylindrical centrioles at its core. Each centriole consists of nine sets of three microtubules held together by proteins. The centrioles are positioned at right angles to each other and surrounded by a shapeless protein cloud called the pericentriolar matrix, or pericentriolar material (PCM).
To ensure that each daughter cell receives a centrosome after cell division, centrosome duplication...
Centrosome Duplication02:25

Centrosome Duplication

The primary microtubule organizing center (MTOC) in animal cells is the centrosome. A centrosome has two cylindrical centrioles at its core. Each centriole consists of nine sets of three microtubules held together by proteins. The centrioles are positioned at right angles to each other and surrounded by a shapeless protein cloud called the pericentriolar matrix, or pericentriolar material (PCM).
To ensure that each daughter cell receives a centrosome after cell division, centrosome duplication...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...